The United States Food and Drug Administration (FDA) inspected your seafood processing facility, located at Fish Island, Stour Road London, E3 2NT, United Kingdom on February 13 – 14, 2020. During that inspection, we found that you have serious violations of the seafood Hazard Analysis and Critical Control Point (HACCP) regulation, Title 21, Code of Federal Regulations, Part 123 (21 CFR 123). At the conclusion of the inspection, the FDA investigator issued an FDA 483, Inspectional Observations, listing the observations made at your firm. We acknowledge receipt of your response sent via email on March 19, 2020. However, our evaluation of your response revealed it was not adequate because it did not include a revised HACCP plan, monitoring records, or an explanation of your corrective actions.